Radient Technologies Inc Stock Toronto S.E.
Equities
CA75034P1062
Pharmaceuticals
Sales 2021 | 2.49M 1.83M | Sales 2022 | 3.62M 2.66M | Capitalization | 29.2M 21.41M |
---|---|---|---|---|---|
Net income 2021 | -42M -30.8M | Net income 2022 | -12M -8.8M | EV / Sales 2021 | 21.6 x |
Net Debt 2021 | 11.44M 8.39M | Net Debt 2022 | 13.67M 10.03M | EV / Sales 2022 | 11.8 x |
P/E ratio 2021 |
-0.85
x | P/E ratio 2022 |
-1.93
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Splinter
FOU | Founder | - | 01-06-11 |
Director of Finance/CFO | - | 14-05-21 | |
Zachary Riauka
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 14-05-21 | |
Steven Splinter
FOU | Founder | - | 01-06-11 |
Jan Petzel
BRD | Director/Board Member | 51 | 16-12-22 |
1st Jan change | Capi. | |
---|---|---|
+37.29% | 6.02B | |
-21.28% | 4.19B | |
+4.52% | 3.25B | |
-18.16% | 2.87B | |
-7.70% | 2.37B | |
+41.50% | 1.89B | |
-4.05% | 1.58B | |
-15.56% | 1.54B | |
-14.62% | 1.5B |